Pharmacist-provided diabetes management and education via a telemonitoring program

Journal of the American Pharmacists Association

Volumn 55, Issue 5, 2015, Pages 516-526

  Shane McWhorter, Laura ^a   McAdam Marx, Carrie ^a   Lenert, Leslie ^b   Petersen, Marta ^a,c   Woolsey, Sarah ^d   Coursey, Jeffrey M ^e,f   Whittaker, Thomas C ^g   Hyer, Christian ^f   LaMarche, Deb ^c   Carroll, Patricia ^c   Chuy, Libbey ^h  

^a UNIVERSITY OF UTAH   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c Utah Telehealth Network   (United States)

^d HEALTHINSIGHT   (United States)

^e UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^f Community Health Centers Inc ^*  (United States)

^g Central City Community Health Centers Inc   (United States)

^h Association for Utah Community Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTICLE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; ELECTRONIC HOUSE CALL DEVICE; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH CENTER; HUMAN; HYPERTENSION; MALE; MEDICAL DEVICE; MEDICAL EDUCATION; MEDICATION COMPLIANCE; PHARMACIST; SYSTOLIC BLOOD PRESSURE; TELEMONITORING; UNITED STATES; AMBULATORY MONITORING; BLOOD; DEVICES; DISEASE MANAGEMENT; MIDDLE AGED; PATIENT EDUCATION; TREATMENT OUTCOME;

DIABETES MELLITUS; DISEASE MANAGEMENT; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; HYPOGLYCEMIC AGENTS; LIPIDS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MONITORING, AMBULATORY; PATIENT EDUCATION AS TOPIC; PHARMACISTS; TREATMENT OUTCOME; UTAH;

EID: 84941925292     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2015.14285     Document Type: Article

References (29)

1. Centers for Disease Control and Prevention. National diabetes statistics report: estimates of diabetes and its burden in the United States, 2014. http://www.cdc.gov/diabetes/pubs/statsreport14/national-diabetes-report-web.pdf. Accessed June 21, 2014.
2. American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care. 2013;36(4):1033-1046.
3. Bohlen K, Scoville E, Shippee ND, et al. Overwhelmed patients: a videographic analysis of how patients with type 2 diabetes and clinicians articulate and address treatment burden during clinical encounters. Diabetes Care. 2012;35(1):47-49.
4. DeArment A. Many patients feel 'overwhelmed' by diabetes management, lack personal care plans, Meijer survey finds. Drug Store News. http://www.drugstorenews.com/article/many-patients-feel-overwhelmed-diabetes-management-lackpersonal-care-plans-meijer-survey-fi. Accessed August 10, 2015.
5. Egede LE, Gebregziabher M, Dismuke CE, et al. Medication nonadherence in diabetes: longitudinal effects on costs and potential cost savings from improvement. Diabetes Care. 2012;35(12):2533-2539.
6. Jha AK, Aubert RE, Yao J, et al. Greater adherence to diabetes drugs is linked to less hospital use and could save nearly $5 billion annually. Health Aff. 2012;31(8):1836-1846.
7. Wubben DP, Vivian EM. Effects of pharmacist outpatient interventions on adults with diabetes mellitus: a systematic review. Pharmacotherapy. 2008;28(4):421-436.
8. Fera T, Bluml BM, Ellis WM. Diabetes Ten City Challenge: final economic and clinical results. J Am Pharm Assoc. 2009;49(3):383-391.
9. Shane-McWhorter L, Oderda GM. Providing diabetes education and care to underserved patients in a collaborative practice at a Utah community health center. Pharmacotherapy. 2005;25(1):96-109.
10. Jameson JP, Baty PJ. Pharmacist collaborative management of poorly controlled diabetes mellitus: a randomized controlled trial. Am J Manag Care. 2010;16(4):250-255.
11. Shane-McWhorter L, Armor B, Johnson JT, et al. Pharmacist scope of practice, standards of practice, and standards of professional performance for diabetes educators. Diabetes Educ. 2009;35(suppl 3):s69-s84.
12. Smith M, Bates DW, Bodenheimer TS. Pharmacists belong in accountable care organizations and integrated care teams. Health Aff. 2013;32(11):1963-1970.
13. Center for Connected Health Policy. Remote patient monitoring. http://cchpca.org/what-is-telehealth/patient-monitoring. Accessed August 10, 2015.
14. Stone RA, Rao RH, Sevick MA, et al. Active care management supported by home telemonitoring in veterans with type 2 diabetes: the DiaTel randomized controlled trial. Diabetes Care. 2010;33(3):478-484.
15. Shea S, Weinstock RS, Teresi JA, et al. A randomized trial comparing telemedicine case management with usual care in older, ethnically diverse, medically underserved patients with diabetes mellitus: 5 year results of the IDEATel study. J Am Med Inform Assoc. 2009;16(4):446-456.
16. Wakefield BJ, Holman JE, Ray A, et al. Effectiveness of home telehealth in comorbid diabetes and hypertension: a randomized, controlled trial. Telemed J E Health. 2011;17(4):254-261.
17. Wakefield BJ, Scherubel M, Ray A, Holman JE. Nursing interventions in a telemonitoring program. Telemed J E Health. 2013;19(3):160-165.
18. Sankaranarayanan J, Sallach RE. Rural patients' access to mobile phones and willingness to receive mobile phonebased pharmacy and other health technology services: a pilot study. Telemed J E Health. 2014;20(2):182-185.
19. Clauson KA, Elrod S, Fox BI, et al. Opportunities for pharmacists in mobile health. Am J Health Syst Pharm. 2013;70(15):1348-1352.
20. Klug C, Bonin K, Bultemeier N, et al. Integrating telehealth technology into a clinical pharmacy telephonic diabetes management program. J Diabetes Sci Technol. 2011;5(5):1238-1245.
21. McFarland M, Davis K, Wallace J, et al. Use of home telehealth monitoring with active medication therapy management by clinical pharmacists in veterans with poorly controlled type 2 diabetes mellitus. Pharmacotherapy. 2012;32(5):420-426.
22. Magid DJ, Olson KL, Billups SJ, et al. A pharmacist-led American Heart Association Heart360 Web-enabled home blood pressure monitoring program. Circ Cardiovasc Qual Outcomes. 2013;6(2):157-163.
23. Margolis KL, Asche SE, Bergdall AR, et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA. 2013;310(1):46-56.
24. Hibbard JH, Mahoney ER, Stockard J, Tusler M. Development and testing of a short form of the patient activation measure. Health Serv Res. 2005;40:1918-1930.
25. Fitzgerald JT, Funnell MM, Hess GE, et al. The reliability and validity of a brief diabetes knowledge test. Diabetes Care. 1998;21(5):706-710.
26. Sanne S, Muntner P, Kawasaki L, et al. Hypertension knowledge among patients from an urban clinic. Ethn Dis. 2008;18(1):42-47.
27. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens. 2008;10(5):348-354.
28. American Diabetes Association. Standards of medical care in diabetes-2014. Diabetes Care. 2014;37(suppl 1):s14-s80.
29. American Diabetes Association. Cardiovascular disease and risk management. Diabetes Care. 2015;38:S49-S57.